Cargando…
Using CRISPR Interference as a Therapeutic Approach to Treat TGFβ2-Induced Ocular Hypertension and Glaucoma
PURPOSE: Primary open angle glaucoma (POAG) is a leading cause of blindness worldwide with elevated intraocular pressure (IOP) as the most important risk factor. POAG IOP elevation is due to pathological changes in the trabecular meshwork (TM). Elevated TGFβ2 contributes to these changes and increas...
Autores principales: | Rayana, Naga Pradeep, Sugali, Chenna Kesavulu, Dai, Jiannong, Peng, Michael, Liu, Shaohui, Zhang, Yucheng, Wan, Jun, Mao, Weiming |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Association for Research in Vision and Ophthalmology
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8434756/ https://www.ncbi.nlm.nih.gov/pubmed/34499703 http://dx.doi.org/10.1167/iovs.62.12.7 |
Ejemplares similares
-
The Role of the Ocular Tissue in SARS-CoV-2 Transmission
por: Peng, Michael, et al.
Publicado: (2020) -
Glucocorticoid Receptor Transactivation Is Required for Glucocorticoid-Induced Ocular Hypertension and Glaucoma
por: Patel, Gaurang C., et al.
Publicado: (2019) -
Comparison of Lamina Cribrosa Morphology in Eyes with Ocular Hypertension and Normal-Tension Glaucoma
por: Kim, Ji-Ah, et al.
Publicado: (2020) -
HDAC Inhibitor-Mediated Epigenetic Regulation of Glaucoma-Associated TGFβ2 in the Trabecular Meshwork
por: Bermudez, Jaclyn Y., et al.
Publicado: (2016) -
Nicotinamide Prevents Retinal Vascular Dropout in a Rat Model of Ocular Hypertension and Supports Ocular Blood Supply in Glaucoma Patients
por: Gustavsson, Simon T., et al.
Publicado: (2023)